Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
Validation of Prognostic Club Cell Secretory Protein (CC16) Cut-point in an Independent ALTA Cohort
CONCLUSION: In this validation study, we demonstrated that ARDS patients with high plasma CC16 concentration had a higher mortality rate than those with low CC16 levels, confirming previous findings that CC16 levels are associated with ARDS mortality.PMID:36814995 | PMC:PMC9940244 | DOI:10.1177/11772719231156308 (Source: Biomarker Insights)
Source: Biomarker Insights - February 23, 2023 Category: General Medicine Authors: Sultan Almuntashiri Aaron Chase Andrea Sikora Duo Zhang Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
What is the Diagnostic Accuracy of Novel Urine Biomarkers for Urinary Tract Infection?
CONCLUSIONS: There is insufficient evidence to recommend the use of any novel biomarker for UTI diagnosis at present. Further evaluation of the more promising candidates, is needed before they can be recommended for clinical use.PMID:36761839 | PMC:PMC9902898 | DOI:10.1177/11772719221144459 (Source: Biomarker Insights)
Source: Biomarker Insights - February 10, 2023 Category: General Medicine Authors: George Edwards Anna Seeley Adam Carter Maia Patrick Smith Elizabeth LA Cross Kathryn Hughes Ann Van den Bruel Martin J Llewelyn Jan Y Verbakel Gail Hayward Source Type: research
